Skip to content

Clinical trials

Mucopolysaccharidosis IV trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis IV Country / region: United States Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20082
20092
20101
20114
20126
20133
20142
20161
20171
20182
20193
20203
20215
20222
20234
20241
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting11
Terminated7
Enrolling by invitation4
Active, not recruiting2
Unknown status1
Approved for marketing1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical8
QED Therapeutics, a BridgeBio company8
University of California, San Francisco3
Emory University2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Nadia Ali, PhD2
Pfizer2
Supplement Formulators, Inc.2
Acuity Polymers, Inc.1
Albert Einstein College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis IV56
Dwarfism11
Genetic Diseases, Inborn10
Osteochondrodysplasias10
Bone Diseases9
Lysosomal Storage Diseases9
Mucopolysaccharidosis VI9
Musculoskeletal Diseases9
Achondroplasia7
Diarrhea7

Trials

Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.